Last reviewed · How we verify

NCT05669859

Efficacy of Postoperative Telerehabilitation in Adolescent Idiopathic Scoliosis

Completed NA Last updated 2 October 2023
What this trial tests

NA trial testing Exercise in Adolescent Idiopathic Scoliosis in 32 participants. Completed in 17 June 2023.

Timeline
17 September 2021
Primary endpoint
17 March 2023
17 June 2023

Quick facts

Lead sponsorHalic University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment32
Start date17 September 2021
Primary completion17 March 2023
Estimated completion17 June 2023
Sites2 locations across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Halic University

Who can join

9 and older, any sex, with Adolescent Idiopathic Scoliosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study, it is aimed to reveal the effects of Tele-Rehabilitation (TR) program, which is designed for the needs of individuals with Adolescent Idiopathic Scoliosis (AIS) who will undergo scoliosis surgery and will be carried out remotely, on pain, trunk endurance, spine flexibility, functional capacity, body appearance perception and quality of life. is intended. With this study, it is aimed to bring evidence-based data on the content of the online rehabilitation program, which can be remotely supervised in the post-surgical period, and the effectiveness and applicability of the applications to the literature. The study was carried out by Emsey Hospital - Advanced Spine Surgery Unit and Prof. Dr. It is planned with at least 34 individuals with AIS who were treated with Posterior Fusion and Instrumentation technique by an orthopedic specialist at Süleyman Yalçın City Hospital. In the randomized controlled design, experimental type planned study, individuals with a minimum of six months and a maximum of two years after surgery will be divided into two groups as the telerehabilitation group and the control group. Individuals in the telerehabilitation group will be included in the Telerehabilitation program, which is planned as two sessions a week, one to one and a half hours, for eight weeks, via remote online video conferencing method. The control group will not be included in any post-surgery rehabilitation program as it is routinely. In the study, pain intensity was determined with the "Numerical Rating Scale", body appearance perception with the "Scoliosis Appearance Questionnaire", quality of life with the "SRS-30 Scoliosis Patient Questionnaire", trunk muscle endurance with "position maintenance tests", flexibility of the spine with "Forward Reaching and Side Bending Tests", exercise capacity will be evaluated with the "Six Minute Walking Test". Evaluation of all cases included in the study was planned at two separate times with 8-week intervals. In the analysis of the data, continuous variables will be given as mean ± standard deviation, qualitative variables as number and percentage (%); statistical tests will be determined according to the distribution of the data, and the significance will be taken as p≤0.05 in all measurements.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Telerehabilitation After Surgery in Adolescent Idiopathic Scoliosis: A Randomized Controlled Trial.
    Çetinkaya İ, Kuru Çolak T, Korkmaz MF, Aydoğan M. · · 2025 · cited 1× · PMID 40868679 · DOI 10.3390/healthcare13162063

Verify or expand the search:

Other trials of Exercise

Trials testing the same drug.

Other recruiting trials for Adolescent Idiopathic Scoliosis

Currently open trials in the same condition.

Other Halic University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05669859.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing